What does evidence show about enteral vs. parenteral feeding strategies in severe, acute pancreatitis?

What does evidence show about enteral vs. parenteral feeding strategies in severe, acute pancreatitis?

• A. EN is contraindicated in severe acute pancreatitis
• B. EN has no effect on infectious complications
• C. PN reduces infectious complications
• D. EN is well tolerated and reduces infectious complications

Answer: (D)

Early enteral nutrition in severe acute pancreatitis helps protect the gut and modulate the body’s response to inflammation. Feeding via the digestive tract preserves the intestinal mucosal barrier, reducing bacterial translocation and the risk of infectious complications that can arise when the gut isn’t used. In practice, enteral feeding is typically started soon after admission (often within 24–48 hours) and is generally well tolerated with a low rate of intolerance when delivered through appropriate routes (gastric or post-pyloric/nasojejunal tubes). In contrast, parenteral nutrition bypasses the gut and carries a higher risk of catheter-related infections, metabolic complications, and sometimes worse overall outcomes, especially if enteral options are feasible. Because of these risks, parenteral nutrition is usually reserved for cases where enteral nutrition cannot be tolerated or is contraindicated. Putting that together, the evidence supports that enteral nutrition is well tolerated and reduces infectious complications in severe acute pancreatitis, making it the preferred feeding strategy when possible.

Early enteral nutrition in severe acute pancreatitis helps protect the gut and modulate the body’s response to inflammation. Feeding via the digestive tract preserves the intestinal mucosal barrier, reducing bacterial translocation and the risk of infectious complications that can arise when the gut isn’t used. In practice, enteral feeding is typically started soon after admission (often within 24–48 hours) and is generally well tolerated with a low rate of intolerance when delivered through appropriate routes (gastric or post-pyloric/nasojejunal tubes).

In contrast, parenteral nutrition bypasses the gut and carries a higher risk of catheter-related infections, metabolic complications, and sometimes worse overall outcomes, especially if enteral options are feasible. Because of these risks, parenteral nutrition is usually reserved for cases where enteral nutrition cannot be tolerated or is contraindicated.

Putting that together, the evidence supports that enteral nutrition is well tolerated and reduces infectious complications in severe acute pancreatitis, making it the preferred feeding strategy when possible.